Supplemental material
Journal of Medical Economics
Volume 23, 2020 - Issue 11
Open access
1,736
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular
Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US
Dejan Milentijevica Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, USA
, Guillaume Germainb Groupe d’analyse, Ltée, Montreal, CanadaCorrespondence[email protected]
, François Lalibertéb Groupe d’analyse, Ltée, Montreal, Canada
, Brahim K. Bookharta Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, USA
, Sean D. MacKnightb Groupe d’analyse, Ltée, Montreal, Canada
, Jenkin Tsangb Groupe d’analyse, Ltée, Montreal, Canada
& Patrick Lefebvreb Groupe d’analyse, Ltée, Montreal, Canada
show all
Pages 1365-1374
|
Received 07 Aug 2020, Accepted 03 Sep 2020, Published online: 29 Sep 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.